Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McMaster University
$105,000.00
Investigating the effects of broadly-neutralizing anti-influenza virus antibodies on immune effector cells
FY 2017-18
Summary
Influenza virus causes the seasonal flu, and is one of the most prevalent viral pathogens worldwide. This virus affects 10% of adults and 20-30% of children across the world, and causes 250 000 to 500 000 deaths every year. Although current flu vaccines are the best way to prevent disease, they must be administered every year and only protect against a few strains of the virus. Influenza vaccine development must also be completed every year, and is a complex and expensive process. The major reason why current influenza vaccines offer transient protection is because the virus mutates frequently and becomes unrecognizable by our immune system from year to year. In the current study, we investigate broadly-neutralizing antibodies, which recognize portions of the virus that are less prone to mutation, and how they interact with cells in our immune system to protect us from infection. The goal of this project is to aid in the development in a universal flu vaccine, which will address the shortfalls inherent to current flu vaccines.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
383427
Name
Zhang Ali
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating the effects of broadly-neutralizing anti-influenza virus antibodies on immune effector cells
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Animal Models; Antibodies; Cell Culture; Elisa; Fluorescence Microscopy; Immune System; Influenza; Vaccine Development
Abstract
Influenza virus causes the seasonal flu, and is one of the most prevalent viral pathogens worldwide. This virus affects 10% of adults and 20-30% of children across the world, and causes 250 000 to 500 000 deaths every year. Although current flu vaccines are the best way to prevent disease, they must be administered every year and only protect against a few strains of the virus. Influenza vaccine development must also be completed every year, and is a complex and expensive process. The major reason why current influenza vaccines offer transient protection is because the virus mutates frequently and becomes unrecognizable by our immune system from year to year. In the current study, we investigate broadly-neutralizing antibodies, which recognize portions of the virus that are less prone to mutation, and how they interact with cells in our immune system to protect us from infection. The goal of this project is to aid in the development in a universal flu vaccine, which will address the shortfalls inherent to current flu vaccines.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Zhang, Ali
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~